⌘K

Login Start Free

Home/Filings/4/0001209191-18-038945

4//SEC Filing

Stejbach Mark 4

Accession 0001209191-18-038945

CIK 0001419600other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:23 PM ET

Size

5.3 KB

Accession

0001209191-18-038945

Insider Transaction Report

Form 4

Period: 2018-06-20

Flexion Therapeutics IncFLXN

Director

Transactions

Award
Stock option (right to buy)
2018-06-20+12,500→ 12,500 total
Exercise: $28.14Exp: 2028-06-19→ Common Stock (12,500 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Flexion Therapeutics Inc

CIK 0001419600

Entity typeother

Related Parties

1

filerCIK 0001487937

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 4:23 PM ET
Size: 5.3 KB

View on SEC.gov